EIF2AK4 and idiopathic pulmonary arterial hypertension: However, a greater cohort study would be required assessing IPAH/HPAH patients for all known PAH genes to investigate the frequency of EIF2AK4 mutations, second hits in PAH and their contribution to disease manifestation within affected families.